Approval · Notice of Compliance 7396 · 1994
HYLAN INJECTION: Notice of Compliance 7396
Issued May 4, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7396
- Date
- May 4, 1994
- Company
- Gp Associates, Inc.Bethlehem, Pennsylvania, United States
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Joint dysfunction associated with equine osteo-arthritis
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYLAN INJECTION | 02091089 | — |
Medicinal ingredients
- HYALURONATE SODIUM 17 MG per ML